Clinical Trials

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

2,700 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06320418 2024-03-20

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

56 enrolled

Ovarian Neoplasms

NCT06317610 2024-03-19

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

100 enrolled

Ovarian Neoplasms

NCT06304922 2024-03-12

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

45 enrolled

Ovarian Neoplasms

NCT06238284 2024-02-02

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04470921 2024-01-26

STOPOVCA

10,000 enrolled

Ovarian Neoplasms, Risk Reduction Behavior

NCT05738902 2024-01-25

ERASGYNBS002

600 enrolled

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Pain, Postoperative, Uterine Neoplasms, Endometrial Neoplasms

NCT06223763 2024-01-25

SUROVA

5,000 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT06222008 2024-01-24

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

40 enrolled

Ovarian Neoplasms, Radiation Injuries, Syndrome

NCT04675320 2023-12-07

IMMUNOPARP

Ovarian Neoplasms

NCT05697601 2023-11-27

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

2,905 enrolled

Endometrial Hyperplasia, Ovarian Neoplasms, Endometrial Neoplasms

NCT06120309 2023-11-07

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer

465 enrolled

Ovarian Neoplasms

NCT06109545 2023-10-31

Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy

95 enrolled

Ovarian Neoplasms

NCT04414683 2023-09-15

Factors Affecting the Prognosis of Early Ovarian Cancer

Ovarian Neoplasms

NCT06037213 2023-09-14

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

500 enrolled

Ovarian Neoplasms

NCT06025045 2023-09-06

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

Ovarian Neoplasms

NCT04768270 2023-08-31

The Culture of Ovarian Cancer Organoids and Drug Screening

30 enrolled

Ovarian Neoplasms

NCT05290961 2023-08-31

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

30 enrolled

Ovarian Neoplasms

NCT05856409 2023-08-16

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

20 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05976932 2023-08-04

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

20 enrolled

Ovarian Neoplasms

NCT05223218 2023-07-03

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

BreastDermatologicGastrointestinalGenitourinaryGynecologic

500 enrolled

Breast Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT04699006 2023-06-15

Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

245 enrolled

Ovarian Neoplasms

NCT03691012 2023-05-09

Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

118 enrolled

Ovarian Neoplasms

NCT05840029 2023-05-03

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

68 enrolled

Ovarian Neoplasms

NCT05824247 2023-04-21

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

60 enrolled

Ovarian Neoplasms

NCT04369352 2023-03-28

Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria

150 enrolled

Ovarian Neoplasms

NCT01061619 2023-03-24

MITO-12

400 enrolled

Ovarian Neoplasms

NCT03561207 2023-03-24

3D-PREDICT

570 enrolled

CNSGynecologic

Astrocytoma, Glioblastoma, Ovarian Neoplasms

NCT05633342 2023-03-20

CADENCE

BreastGastrointestinalGenitourinaryGynecologic

15,000 enrolled

Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

150 enrolled

Ovarian Neoplasms

NCT05763472 2023-03-10

Gen-eva

10 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04752865 2023-03-01

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Ovarian Neoplasms

NCT05265117 2023-02-17

The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study

310 enrolled

Ovarian Neoplasms

NCT05693974 2023-01-23

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)

130 enrolled

Ovarian Neoplasms

NCT05693987 2023-01-23

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)

248 enrolled

Ovarian Neoplasms

NCT05685524 2023-01-17

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

3,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04770376 2022-12-29

Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab

150 enrolled

Ovarian Neoplasms

NCT05642871 2022-12-08

DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene

2 enrolled

Ovarian Neoplasms

NCT05640024 2022-12-07

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

54 enrolled

Ovarian Neoplasms

NCT05583799 2022-10-18

Efficacy and Adverse Effects of Niraparib in Ovarian Cancer.

222 enrolled

Ovarian Neoplasms

NCT05576519 2022-10-12

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Ovarian Neoplasms

NCT05537844 2022-09-23

BriTROC-2

250 enrolled

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05458973 2022-09-13

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.

100 enrolled

Ovarian Neoplasms

NCT05523804 2022-08-31

GO SOAR2

800 enrolled

Ovarian Neoplasms

NCT05461872 2022-08-15

Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES

Ovarian Cysts, Ovarian Neoplasms

NCT05496517 2022-08-11

OCISS

1,000 enrolled

Ovarian Neoplasms

NCT05440578 2022-07-01

First-line Olaparib Combined With Bevacizumab Maintenance Therapy

Ovarian Neoplasms

NCT05410015 2022-06-08

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer

Ovarian Neoplasms

NCT05410028 2022-06-08

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

1,000 enrolled